TICKERNERD
Menu
BRKRBRKRHealthcare · Medical Devices

BRKR Stock Forecast: Bruker Corp. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$64
+2.34% on the day

The 13 Wall Street analysts covering Bruker Corp. hold a median 12-month price target of $60 — -6.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 73 of 100 as at 1 Aug 2026 — in the upper half. The factors read stronger than the Street's target implies. That gap is the story on this page.

Market cap
$9.6B
Ticker Nerd rank
73 / 100
Median analyst target
$60
Analysts covering
13
Total return, dividends reinvested
1W
+7.1%
1M
+4.3%
YTD
+36.8%
1Y
+70.1%
From 52W high
−0.0%
From 52W low
+120.2%
$29
$64
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BRKR stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Bruker Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
73 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
88
Value
81
Momentum
66
Quality
65
Revisions
65
Volatility
62
Growth
50
Accruals
47
Size
16

Issuance (88): The share count has been shrinking and the company is not leaning on new borrowing.

Accruals (47): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (16): Larger than most of the companies we track — more scrutinised, less often mispriced.

The rank is the raw material. Whether the rules would actually own Bruker Corp. — and when they’d sell — is the membership.

Wall Street

BRKR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BRKR, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$30$40$50$60$70Oct 25Jan 26Apr 26Jul 26BRKRHigh $70Median $60Low $40

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says13 analysts
8 Buy4 Hold1 Sell
Low $40Median $60High $70

The green dot is the last close — the median target sits −6.7% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
8 July 2026CitigroupMaintainsNeutral$44 → $60
7 July 2026Leerink PartnersMaintainsOutperform$60 → $70
29 June 2026GuggenheimMaintainsBuy—
24 June 2026BarclaysMaintainsOverweight—
8 June 2026JP MorganMaintainsOverweight—
2 June 2026Wolfe ResearchAssumesPeer Perform—
7 May 2026BarclaysMaintainsOverweight—
7 May 2026CitigroupMaintainsNeutral—
7 May 2026TD CowenMaintainsHold—
7 May 2026UBSMaintainsNeutral—
15 Apr 2026BarclaysMaintainsOverweight—
14 Apr 2026BarclaysMaintainsOverweight—
30 Mar 2026GuggenheimMaintainsBuy—
13 Feb 2026BarclaysMaintainsOverweight—
13 Feb 2026CitigroupMaintainsNeutral—
13 Feb 2026Goldman SachsMaintainsSell—
13 Feb 2026TD CowenMaintainsHold—
26 Jan 2026GuggenheimMaintainsBuy—
16 Jan 2026CitigroupMaintainsNeutral—
7 Jan 2026TD CowenMaintainsHold—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

BRKR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.2%
Analysts raising
3
Analysts cutting
1
Fundamentals

Bruker Corp. (BRKR) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
74.9×

Cheaper than 10% of US stocks

Price / sales
2.8×

Cheaper than 44% of US stocks

Price / book
3.9×

Cheaper than 27% of US stocks

EV / EBITDA
22.9×

Cheaper than 13% of US stocks

Growth & margins
Revenue growth (YoY)
2.7%

Higher than 36% of US stocks

Earnings growth (YoY)
−17.2%

Higher than 21% of US stocks

Gross margin
46.1%

Higher than 59% of US stocks

Operating margin
6.2%

Higher than 60% of US stocks

Net margin
−0.3%

Higher than 30% of US stocks

Returns & dividend
Return on equity
−0.4%

Higher than 43% of US stocks

Return on assets
2.7%

Higher than 64% of US stocks

Dividend yield
0.3%

Higher than 6% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

BRKR vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
BRKRBruker Corp.$9.6B
73
GKOSGlaukos Corp.$9.8B
87
GMEDGlobus Medical, Inc.$10.6B
86
BIOBio-Rad Laboratories, Inc.$8.6B
82
PODDInsulet Corp.$11.5B
95
PENPenumbra, Inc.$12.6B
71
ZBHZimmer Biomet Holdings, Inc.$18.6B
79
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BRKR appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest BRKR news & analysis

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

Business Wire · 24 July 2026neutral

Bruker Corporation announced it will report second quarter 2026 financial results before market opening on Tuesday, August 4, 2026, followed by a conference call and webcast at 9:00 a.m. Eastern Daylight Time.

Why it matters — The announcement provides investors and analysts with the scheduled date and details for accessing Bruker's Q2 2026 earnings report and management commentary on business trends.

FAQ

Frequently asked questions about BRKR stock

What is the BRKR stock price forecast for 2026-2027?

The 13 Wall Street analysts covering Bruker Corp. have a median 12-month price target of $60, with estimates ranging from $40 to $70. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is BRKR stock a buy right now?

Of the 13 analysts covering Bruker Corp., 8 rate it a Buy, 4 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Bruker Corp. 73 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank BRKR?

As at 1 Aug 2026, Bruker Corp. ranks 73 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (88 of 100).

Will BRKR stock go up?

No one can know that. What the data says: the median 12-month target from 13 analysts implies -6.7% from the last close, and Ticker Nerd's factor model ranks Bruker Corp. 73 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the BRKR stock forecast for 2030?

No analyst covering Bruker Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BRKR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $40 to $70 over the next 12 months.

How has BRKR stock performed over the past year?

Bruker Corp. returned +70.1% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Bruker Corp. do?

Bruker Corporation is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions that enable molecular and materials research across academic, governmental, and industrial laboratories worldwide. The company designs and distributes nuclear magnetic resonance spectrometers, mass spectrometry platforms, X-ray diffraction instruments, atomic force microscopes, and preclinical imaging systems such as micro-CT and MRI scanners.

What is the latest news on BRKR?

The most recent item we track (Business Wire, 24 July 2026): "Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast". Bruker Corporation announced it will report second quarter 2026 financial results before market opening on Tuesday, August 4, 2026, followed by a conference call and webcast at 9:00 a.m. Eastern Daylight Time.

Company

About Bruker Corp.

Bruker Corporation is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions that enable molecular and materials research across academic, governmental, and industrial laboratories worldwide. The company designs and distributes nuclear magnetic resonance spectrometers, mass spectrometry platforms, X-ray diffraction instruments, atomic force microscopes, and preclinical imaging systems such as micro-CT and MRI scanners. In addition to hardware, Bruker provides comprehensive software suites, applications support, training services, and long-term maintenance agreements to optimize instrument performance. The company serves diverse customer segments in the pharmaceutical, biotechnology, chemical, semiconductor, energy, and environmental sectors through four primary business segments: Bruker Scientific Instruments BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. With research and development, manufacturing, and service centers located throughout the Americas, Europe, and Asia, Bruker maintains a global infrastructure to support its worldwide customer base. Founded in 1960 and headquartered in Billerica, Massachusetts, the company continues to play a significant role in advancing scientific research and analysis globally.

CEO Dr. Frank H. Laukien Ph.D. · 11,085 employees · United States · https://www.bruker.com